Key result
Lipopolysaccharide induces cardiac ion channel dysfunction in hiPSC-CMs via ECRG4 upregulation and altered NFκB signaling.
Why the study?
ECRG4 modulates cardiomyocyte ion channel function and electrical activity, but the exact mechanism underlying its contribution to inflammation-induced ion channel dysfunctions remains unknown.
Answers are grounded in this paper and cite their sources.
ECRG4 mediates LPS-induced cardiac ion channel dysfunction via NFκB signaling in hiPSC-CMs, suggesting a potential mechanism for inflammation-induced arrhythmias.
Background and Purpose: Esophageal cancer-related gene-4 (ECRG4) participate in inflammation process and can interact with the innate immunity complex TLR4-MD2-CD14 on human granulocytes. In addition, ECRG4 participate in modulation of ion channel function and electrical activity of cardiomyocytes. However, the exact mechanism is unknown. This study aimed to test our hypothesis that ECRG4 contributes to inflammation-induced ion channel dysfunctions in cardiomyocytes. Methods: Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) generated from three donors were treated with lipopolysaccharide (LPS) to establish an endotoxin-induced inflammatory model. Immunostaining, real-time PCR, and patch-clamp techniques were used for the study. Results: ECRG4 was detected in hiPSC-CMs at different differentiation time. LPS treatment increased ECRG4 expression in hiPSC-CMs. Knockdown of ECRG4 decreased the expression level of Toll-Like-Receptor 4 (TLR4, a LPS receptor) and its associated genes and inflammatory cytokines. Furthermore, ECRG4 knockdown shortened the action potential duration (APD) and intercepted LPS-induced APD prolongation by enhancing I SK (small conductance calcium-activated K channel current) and attenuating I NCX (Na/Ca exchanger current). Overexpression of ECRG4 mimicked LPS effects on I SK and I NCX , which could be prevented by NFκB signaling blockers. Conclusion: This study demonstrated that LPS effects on cardiac ion channel function were mediated by the upregulation of ECRG4, which affects NFκB signaling. Our findings support the roles of ECRG4 in inflammatory responses and the ion channel dysfunctions induced by LPS challenge.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2024) studied Endotoxin-induced inflammation and ion channel dysfunction (n=3). Lipopolysaccharide (LPS) and ECRG4 knockdown/overexpression vs. Untreated/control hiPSC-CMs was evaluated on Action potential duration (APD) and ion channel currents (ISK and INCX). Lipopolysaccharide-induced cardiac ion channel dysfunction in hiPSC-CMs was mediated by ECRG4 upregulation, which altered NFκB signaling, enhanced ISK, and attenuated INCX.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: